Inclusion Criteria:~* men \& women 50-75 years~* post-menopausal or women not of child-bearing potential~*
diagnosis of Alzheimer's disease based on National Institute for Aging:~* Biomarker classification A+T+N+ or
A+T+N-~* Clinical Stage 3 or 4 with Clinical Dementia Rating score ≥ 0.5 \& ≤ 1; mini-mental state examination
(MMSE) score ≥20~* Have an APOE genotype of E4/E4 or E3/E4~* not on or on stabilized AD medication~* Patient \&
study partner willing to sign consent~
